Marijuana and Cannabinoids: A Neuroscience Research Summit was convened by the National Institutes of Health (NIH) to focus on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system were discussed. The goal of this summit was to make evidence-based information available to inform practice and policy, particularly important at this time given the rapidly shifting landscape regarding the recreational and medicinal use of marijuana.
The United States and Mexico have issued a joint declaration (PDF, 43.8KB) of cooperation on drug demand reduction efforts that underscores a commitment to reduce illicit drug consumption and the need to work collaboratively with each other and additional partners in the region. The joint declaration was issued at the conclusion of the 8th U.S.–Mexico Bi-National Drug Demand Reduction Policy Meeting, which was held at the U.S.